SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
NextCure, Inc.
@NXTC_InsiderForm 4 Filing: ADAR1 Capital Management, LLC Buys $87,712.761 of $NXTC
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
NextCure, Inc.
Ticker: $NXTC
Transaction Value
$87,712.761
Price/Share: $4.98
transaction date
2026-07-27
Shares: 17,608
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ADAR1 Capital Management, LLC, holds the title of 10% Owner at NextCure, Inc..
On 2026-07-27, the insider transacted 17,608 shares.The shares were transacted at a weighted average price of $4.98 per share, resulting in a total market-relevant value of $87,712.761.
Executive Summary Summary
ADAR1 Capital Management, LLC (10% Owner) bought $88K of $NXTC
Post-Transaction Position: 383,456 shares
SEC Accession No: 0001940272-26-000012 (CIK: 1940272)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.